Back to Basics: Designing digital patient services

Elisa del Galdo | 2nd July 2015


 

Head of Customer Experience Elisa del Galdo talks through the key considerations for pharma companies when designing and delivering digital patient services from a customer experience perspective.

As pharma marketing departments increasingly look towards digital services and solutions, there are a number of important considerations that companies cannot afford to neglect. Understanding client objectives should be the first port of call. When talking about innovation in marketing, the creation of digital services and multi-platform offerings often comes up. There has been a great deal of innovation applied to the provision of digital services and solutions within the pharmaceutical industry, in spite of the unique challenges created by strict regulations on the marketing of medical products. That said, the design and development of customer-focused services and solutions is a relatively new approach in this sector.

 

To read more, download the full PDF of this article, as it appeared in the IPT Online - Innovations in Pharmaceutical Technology June 2015 issue.  

What does programmatic advertising mean for your pharma marketing strategy?

Jiayi Chen | 11th January 2018

Senior Associate Consultant Jiayi Chen explains the benefits and pitfalls of programmatic advertising and reveals how it can impact return on investment in your marketing campaigns.

 

read more

How to measure marketing success: profit vs ROI

Paul Townley-Jones | 4th January 2018

Measuring marketing activity is proving to be a major challenge in pharma. Here, Senior Consultant Paul Townley-Jones explores the meaning of success and gives his tips for measuring efficiency and effectiveness, along with the formula for calculating profit and ROI.

read more

Warning signs: making the most of multichannel marketing

Chris Ross | 5th December 2017

Pharma is making measured progress in its adoption of multichannel marketing. But can it actually measure success? And does it even know what good looks like? Chris Ross interviews Senior Consultant Paul Towney Jones to explore the risks and benefits of increased investment in MCM.

read more